JENBURKT PHARMACEUTICALS
Back to Balance Sheet
|
JENBURKT PHARMACEUTICALS Last 5 Year Contingent Liabilities History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹17 Cr | ₹16 Cr | ₹17 Cr | ₹20 Cr | ₹17 Cr |
What is the latest Contingent Liabilities ratio of JENBURKT PHARMACEUTICALS ?
| Year | Contingent Liabilities |
|---|---|
| Mar2026 | ₹17 Cr |
| Mar2025 | ₹16 Cr |
| Mar2024 | ₹17 Cr |
| Mar2023 | ₹20 Cr |
| Mar2022 | ₹17 Cr |
How is Contingent Liabilities of JENBURKT PHARMACEUTICALS Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹17 Cr | 4.24 | |
| Mar2025 | ₹16 Cr | -0.45 | |
| Mar2024 | ₹17 Cr | -15.25 | |
| Mar2023 | ₹20 Cr | 17.75 | |
| Mar2022 | ₹17 Cr | - | |
Compare Contingent Liabilities of peers of JENBURKT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| JENBURKT PHARMACEUTICALS | ₹392.5 Cr | -2.8% | -13.8% | -17.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹427,861.0 Cr | -2% | -6.1% | 12.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹254,319.0 Cr | 3.2% | 5.3% | 67.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹179,153.0 Cr | -1.9% | -2.9% | 32.7% | Stock Analytics | |
| CIPLA | ₹107,406.0 Cr | -1.5% | -4% | -10.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,362.0 Cr | -2.7% | 4.2% | -1.2% | Stock Analytics | |
JENBURKT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| JENBURKT PHARMACEUTICALS | -2.8% |
-13.8% |
-17.9% |
| SENSEX | 0.2% |
-4.6% |
-9.6% |
You may also like the below Video Courses